A phase II trial of low-dose total body irradiation and subcutaneous Interleukin-2 in metastatic melanoma

Radiotherapy and Oncology

Volumn 77, Issue 2, 2005, Pages 143-147

  Safwat, Akmal ^a   Schmidt, Henrik ^a   Bastholt, Lars ^b   Fode, Kirsten ^a   Larsen, Susanne ^b   Aggerholm, Ninna ^a   Von Der Maase, Hans ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Interleukin 2; Low dose whole body irradiation; Melanoma; Metastatic disease

Indexed keywords

CD20 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER REGRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG MEGADOSE; DYSPNEA; DYSTHYMIA; FATIGUE; FEMALE; FLOW CYTOMETRY; HUMAN; HYPOTENSION; IMMUNOCOMPETENT CELL; INFECTION; LETHARGY; LIVER TOXICITY; LUNG DISEASE; MALE; MELANOMA; METASTASIS; MONOCYTE; MORBIDITY; NATURAL KILLER CELL; NAUSEA; NEUROTOXICITY; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SIDE EFFECT; SKIN DISEASE; THROMBOCYTOPENIA; UPPER GASTROINTESTINAL TRACT; VISCERA; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; WHOLE BODY RADIATION;

ADULT; AGED; DENMARK; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-2; MALE; MAXIMUM TOLERATED DOSE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 27944475888     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.09.008     Document Type: Article

References (18)

1. J.A. DelRegato Total body irradiation in the treatment of chronic lymphogenous leukemia Am J Roentgenol 120 1974 504 520
2. O. Eton, M.G. Rosenblum, and S.S. Legha Phase II trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma Cancer 95 2002 127 134
3. A. Fourquet, J.L. Teillaud, D. Lando, and W.H. Fridman Effects of low dose total body irradiation and recombinant human interlukin-2 in mice Radiother Oncol 26 1993 219 225
4. C. Gray, P. Arosio, and P. Hersey Association of increased levels of heavy chain Ferritin with increased CD4+CD25+ regulatory cell levels in patients with melanoma Clin Cancer Res 9 2003 2551 2559
5. Y. Ibuki, and R. Goto Enhancement of concavalin A-induced proliferation of spleno-lymphocytes by low-dose-irradiatiated macrophages J Radiat Res (Tokyo) 35 1994 83 91
6. S. Kojima, H. Ishida, M. Takahashi, and K. Yamaoka Elevation of glutathione induced by low-dose gamma rays and its involvement in increased natural killer activity Radiat Res 157 2002 275 280
7. S.Z. Liu, Xu. Su, Y.C. Zhang, and Y. Zhao Signal transduction in lymphocytes after low dose radiation Chin Med J Engl 107 1994 431 436
8. P.M. Richaud, P. Soubeyran, and H. Eghbali Place of low-dose total body irradiation in the treatment of localized follicular NHL: results of a pilot study Int J Radiat Oncol Biol Phys 40 1998 387 390
9. S.A. Rosenberg, J.J. Mulé, P.J. Spiess, C.M. Reichert, and S.L. Schwarz Regression of established pulmonary metastases and subcutaneous tumour mediated by the systemic administration of high dose recombinant interleukin 2 J Exp Med 161 1985 1169 1188
10. S.A. Rosenberg, J.C. Yang, and D.E. White Durability of complete responses in patients with metastatic cancer treated with high dose interleukin-2: identification of the antigens mediating response Ann Surg 228 1998 307 319
11. A. Safwat The immune-biology of low-dose total body irradiation: more questions than answers Radiat Res 153 2000 599 604
12. A. Safwat, N. Aggerholm, I. Roitt, J. Overgaard, and M. Hokland Tumour burden and Interleukin-2 (IL-2) dose affect the interaction between low-dose total body irradiation and interleukin-2 Eur J Cancer 2004
13. A. Safwat, N. Aggerhom, I. Roitt, J. Overgaard, and M. Hokland Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma J Exp Therap Oncol 3 2003 161 168
14. H. Schmidt, P.F. Geertsen, K. Fode, C. Rytter, L. Bastholt, and H. von der Maase Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with anf without prophylactic cimitidine in patients with metastatic melanoma: a phase II study Melanoma Res 10 2000 66 77
15. R.N. Shen, L. Lu, G.S. Feng, J. Miller, M.W. Taylor, and H.E. Broxmeyer Cure with low-dose total body irradiation of the hematological disorder induced in mice with Friend virus: possible mechanism involving interferon-gamma and interleukin-2 Lymphokine Cytokine Res 10 1991 105 109
16. R.N. Shen, L. Lu, H.E. Kaiser, and H.E. Broxmeyer Murine AIDS cured by low dosage total body irradiation Adv Exp Med Biol 407 1997 451 458
17. P. Therasse, A.G. Arbuck, and E.A. Eisenhaur New guidlines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
18. D.M. Yonkosky, M.I. Feldman, E.S. Cathcart, and S. Kim Improvement of in-vitro mitogen proliferative reponses in non-Hodgkin's lymphoma patients exposed to fractionated total body irradiation Cancer 42 1978 1204 1210